How might Baxter International redesign its Floseal Hemostatic Matrix to make it easier for surgeons to apply during procedures?

Introduction

To redesign Baxter International's Floseal Hemostatic Matrix for easier application by surgeons during procedures, we need to deeply understand the current product, its users, and the surgical environment. I'll analyze the key stakeholders, pain points, and potential solutions to improve this critical medical device. Let's begin by clarifying some crucial aspects of the product and its usage.

Step 1

Clarifying Questions (5 mins)

• Looking at the product context, I'm thinking about the specific surgical specialties where Floseal is most commonly used. Could you provide insight into the top 2-3 surgical specialties that rely on Floseal, and their unique application requirements?

Why it matters: Different surgical specialties may have varying needs and constraints, which could significantly impact our redesign approach. Expected answer: Cardiovascular, orthopedic, and neurosurgery are the primary specialties. Impact on approach: We'd tailor our solutions to address the specific challenges in these high-stakes environments.

• Considering user behavior, I'm curious about the current application process. Can you walk me through the step-by-step procedure surgeons follow to apply Floseal during a typical operation?

Why it matters: Understanding the current workflow will help us identify specific pain points and opportunities for improvement. Expected answer: A multi-step process involving preparation, application, and monitoring. Impact on approach: We'd focus on streamlining the most cumbersome steps in the process.

• Regarding pain points and market position, how does Floseal compare to alternative hemostatic agents in terms of efficacy and ease of use? Are there specific areas where surgeons find Floseal superior or inferior to competitors?

Why it matters: This information will help us understand Floseal's unique value proposition and areas for improvement relative to the competition. Expected answer: Floseal is highly effective but may be more challenging to apply than some alternatives. Impact on approach: We'd prioritize ease of use improvements while maintaining Floseal's superior efficacy.

• From a product lifecycle perspective, I'm interested in understanding recent innovations or iterations in Floseal's design. What major changes or improvements has Baxter made to Floseal in the past 3-5 years?

Why it matters: This will help us avoid duplicating recent efforts and identify areas that haven't been addressed yet. Expected answer: Minor packaging improvements, but no significant changes to the application process. Impact on approach: We'd focus on bold, transformative ideas rather than incremental changes.